查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1356791

肝病诊断市场报告：2030 年趋势、预测与竞争分析

Liver Disease Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

肝病诊断药物的发展趋势与预测

预计到 2030 年，全球肝病诊断市场将达到 505 亿美元，2024 年至 2030 年年复合成长率为 6.2%。这个市场的主要驱动因素是肝病盛行率的增加、酒精消费量的增加以及为患者进行准确和早期诊断而增加的研发支出。全球肝病诊断市场的未来充满希望，医院和研究机构市场存在商机。

肝病诊断市场洞察

Lucintel 预测，在预测期内，影像倡议仍将是最大的细分市场，因为肝病诊断市场的主要企业正在采取众多措施来开发先进的影像技术。

由于住院人数的增加、先进诊断产品的可得性以及训练有素的护理人员的存在，医院仍然是该市场中最大的部分。

由于医疗保健支出增加、老年人口增加以及定期检查意识增强，预计亚太地区将在预测期内实现最高增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球肝病诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球肝病诊断市场趋势（2018-2023）与预测（2024-2030）
  • 按诊断技术分類的全球肝病诊断市场
    • 成像
    • 临床检查
    • 内视镜
    • 切片检查
    • 其他的
  • 按最终用途分類的全球肝病诊断市场
    • 医院
    • 实验室
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 按地区分類的全球肝病诊断市场
  • 北美肝病诊断市场
  • 欧洲肝病诊断市场
  • 亚太地区肝病诊断市场
  • 其他区域肝病诊断市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 诊断技术的全球肝病诊断市场成长机会
    • 全球肝病诊断市场成长机会（依最终用途）
    • 全球肝病诊断市场按地区成长机会
  • 全球肝病诊断市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球肝病诊断市场的产能
    • 全球肝病诊断市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Abbott
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Boston Scientific Corporation
  • Laboratory Corporation of America Holdings
  • Fujifilm Corporation
  • Horiba Medical
  • Siemens Healthcare
简介目录

Liver Disease Diagnostics Trends and Forecast

The future of the global liver disease diagnostics market looks promising with opportunities in the hospital and laboratoy markets. The global liver disease diagnostics market is expected to reach an estimated $50.5 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are increasing prevalence of liver diseases, rising alcohol consumption, and growing expenditure on research and development for accurate and early diagnosis of patients.

A more than 150-page report is developed to help in your business decisions.

Liver Disease Diagnostics by Segment

The study includes a forecast for the global liver disease diagnostics by diagnosis technique, end use, and region.

Liver Disease Diagnostics Market by Diagnosis Technique [Shipment Analysis by Value from 2018 to 2030]:

  • Imaging
  • Laboratory tests
  • Endoscopy
  • Biopsy
  • Others

Liver Disease Diagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Laboratories
  • Others

Liver Disease Diagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Liver Disease Diagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies liver disease diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the liver disease diagnostics companies profiled in this report include-

  • Abbott
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Boston Scientific Corporation
  • Laboratory Corporation Of America Holdings
  • Fujifilm Corporation
  • Horiba Medical
  • Siemens Healthcare

Liver Disease Diagnostics Market Insights

Lucintel forecasts that imaging will remain the largest segment over the forecast period due to the growing number of initiatives taken by key players in the market for liver disease diagnostics so as to develop advanced imaging techniques.

Within this market, hospitals will remain the largest segment due to growing admission of patient, availability of advanced diagnostic products, and presence of well-trained nursing staff.

APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, growing geriatric population, and rising awarness towards regular checkups in the region.

Features of the Global Liver Disease Diagnostics Market

Market Size Estimates: Liver disease diagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Liver disease diagnostics market size by diagnosis technique, end use, and region. in terms of value ($B).

Regional Analysis: Liver disease diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnosis techniques, end uses, and region.s for the liver disease diagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the liver disease diagnostics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the liver disease diagnostics market size?

Answer: The global liver disease diagnostics market is expected to reach an estimated $50.5 billion by 2030.

Q.2. What is the growth forecast for liver disease diagnostics market?

Answer: The global liver disease diagnostics market is expected to grow with a CAGR of 6.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the liver disease diagnostics market?

Answer: The major drivers for this market are increasing prevalence of liver diseases, rising alcohol consumption, and growing expenditure on research and development for accurate and early diagnosis of patients.

Q.4. What are the major segments for liver disease diagnostics market?

Answer: The future of the liver disease diagnostics market looks promising with opportunities in the hospitals and laboratories markets.

Q.5. Who are the key liver disease diagnostics market companies?

Answer: Some of the key liver disease diagnostics companies are as follows:

  • Abbott
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Boston Scientific Corporation
  • Laboratory Corporation of America Holdings
  • Fujifilm Corporation
  • Horiba Medical
  • Siemens Healthcare

Q.6. Which liver disease diagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that imaging will remain the largest segment over the forecast period due to the growing number of initiatives taken by key players in the market for liver disease diagnostics so as to develop advanced imaging techniques.

Q.7. In liver disease diagnostics market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, growing geriatric population, and rising awarness towards regular checkups in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the liver disease diagnostics market by diagnosis technique (imaging, laboratory tests, endoscopy, biopsy, and others), end use (hospitals, laboratories, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Liver Disease Diagnostics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Liver Disease Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Liver Disease Diagnostics Market by Diagnosis Technique
    • 3.3.1: Imaging
    • 3.3.2: Laboratory tests
    • 3.3.3: Endoscopy
    • 3.3.4: Biopsy
    • 3.3.5: Others
  • 3.4: Global Liver Disease Diagnostics Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Laboratories
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Liver Disease Diagnostics Market by Region
  • 4.2: North American Liver Disease Diagnostics Market
    • 4.2.2: North American Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others
  • 4.3: European Liver Disease Diagnostics Market
    • 4.3.1: European Liver Disease Diagnostics Market by Diagnosis Technique: Imaging, Laboratory Tests, Endoscopy, Biopsy, and Others
    • 4.3.2: European Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others
  • 4.4: APAC Liver Disease Diagnostics Market
    • 4.4.1: APAC Liver Disease Diagnostics Market by Diagnosis Technique: Imaging, Laboratory Tests, Endoscopy, Biopsy, and Others
    • 4.4.2: APAC Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others
  • 4.5: ROW Liver Disease Diagnostics Market
    • 4.5.1: ROW Liver Disease Diagnostics Market by Diagnosis Technique: Imaging, Laboratory Tests, Endoscopy, Biopsy, and Others
    • 4.5.2: ROW Liver Disease Diagnostics Market by End Use: Hospitals, Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Liver Disease Diagnostics Market by Diagnosis Technique
    • 6.1.2: Growth Opportunities for the Global Liver Disease Diagnostics Market by End Use
    • 6.1.3: Growth Opportunities for the Global Liver Disease Diagnostics Market by Region
  • 6.2: Emerging Trends in the Global Liver Disease Diagnostics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Liver Disease Diagnostics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Liver Disease Diagnostics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Thermo Fisher Scientific
  • 7.4: Randox Laboratories
  • 7.5: Boston Scientific Corporation
  • 7.6: Laboratory Corporation of America Holdings
  • 7.7: Fujifilm Corporation
  • 7.8: Horiba Medical
  • 7.9: Siemens Healthcare